Diarrheal deaths in children living in New Mexico: toward a strategy of preventive interventions

C Bern1, J Lew, P McFeeley

  • 1Viral Gastroenteritis Unit, Centers for Disease Control and Prevention, Atlanta, GA 30333.

Insights

Preventing childhood diarrhea deaths requires educating parents on early treatment seeking and healthcare providers on recognizing fatal dehydration risks in infants. This study reviewed 26 cases from 1980-1989.

Area of Science:

  • Pediatrics
  • Public Health
  • Epidemiology

Background:

  • Childhood diarrhea remains a significant cause of mortality globally.
  • In New Mexico, specific demographic and healthcare-seeking patterns were observed in fatal cases.
  • Understanding these patterns is crucial for developing targeted prevention strategies.

Purpose of the Study:

  • To review childhood diarrheal deaths in New Mexico from 1980-1989.
  • To identify circumstances associated with these deaths for prevention strategy development.

Main Methods:

  • Retrospective review of 26 childhood diarrheal deaths.
  • Data collected by the New Mexico Office of the Medical Investigator.
  • Analysis of demographic factors and healthcare interactions.

Main Results:

  • Most deaths (88%) occurred in children younger than 9 months.
  • Minority groups were disproportionately affected (American Indian 54%, Hispanic 23%).
  • Nearly half (46%) of children had seen a physician within 3 days of death.

Conclusions:

  • Early recognition of dehydration by healthcare providers is critical.
  • Parental education on seeking timely medical treatment is essential.
  • Targeted interventions can help reduce preventable diarrheal deaths in vulnerable populations.

Related Concept Videos

Methods Of Healthcare Delivery System01:26

Methods Of Healthcare Delivery System

At the different levels of the healthcare system, we see varying methods of healthcare used. These methods include managed care systems, case management, and primary healthcare.
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is limited...
Transmission-based Precautions I: Contact, Enteric, and Droplets01:17

Transmission-based Precautions I: Contact, Enteric, and Droplets

Transmission-based precautions are for patients known to be infected or suspected to be infected or colonized with organisms that pose a significant risk to others. Some transmission-based precautions include contact, enteric, and droplet.
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Cholera01:25

Cholera

Cholera is an acute gastrointestinal disease caused by the Gram-negative bacterium Vibrio cholerae. It is transmitted primarily via the fecal-oral route through the ingestion of contaminated water or food.Vibrio cholerae is a motile, Gram-negative bacterium of the family Vibrionaceae, primarily associated with waterborne outbreaks in areas with inadequate sanitation. Although over 200 serogroups of V. cholerae exist, only O1 and O139 are responsible for epidemic cholera. The O1 serogroup,...